(Q38139293)

29 August 2017

title

Adipose tissue inflammation in glucose metabolism (English)

1 reference

29 August 2017

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

H L Kammoun

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M A Febbraio

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

1 March 2014

1 reference

Reviews in Endocrine and Metabolic Disorders

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

31-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048715%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11154-013-9274-4

13 June 2020

exact match

0 references

cites work

Molecular mechanisms of cancer development in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Obesity, insulin resistance, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The role of adipose tissue and adipokines in obesity-related inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Macrophage-mediated inflammation in metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Subcutaneous and visceral adipose tissue: structural and functional differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

CD11c expression in adipose tissue and blood and its role in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipose tissue foam cells are present in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Innate immune activation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

White blood cell count and abdominal fat distribution in female obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Body fat and circulating leukocytes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

RAG-1-deficient mice have no mature B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

IL-17 regulates adipogenesis, glucose homeostasis, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The adipocyte as an endocrine organ in the regulation of metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Dynamics of fat cell turnover in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Metabolic signatures of human adipose tissue hypoxia in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Hypoxia and adipose tissue function and dysfunction in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11β-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Insulin resistance is a cellular antioxidant defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Measurement of the increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Inflammation during obesity is not all bad: evidence from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Prevention of fat-induced insulin resistance by salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The ancient drug salicylate directly activates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Salsalate improves glycemia and inflammatory parameters in obese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

PPAR gamma and human metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Fat and beyond: the diverse biology of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Does therapy with anti-TNF-alpha improve glucose tolerance and control in patients with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-1 beta targeted therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

21 January 2018

New therapies for gout.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Anakinra for rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

The immune system as a sensor of the metabolic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Inflammation and resolution are associated with upregulation of fatty acid β-oxidation in Zymosan-induced peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Circulating white blood cell count and measures of adipose tissue inflammation predict higher 24-h energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Hypothalamic inflammation and energy homeostasis: resolving the paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Identification of body fat mass as a major determinant of metabolic rate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9274-4

Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure

21 January 2018

1 reference

12 December 2020

Saturated fatty acids do not directly stimulate Toll-like receptor signaling

1 reference

12 December 2020

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

1 reference

12 December 2020

Adipocyte death, adipose tissue remodeling, and obesity complications

1 reference

12 December 2020

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

1 reference

12 December 2020

Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity

1 reference

12 December 2020

PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells

1 reference

12 December 2020

Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Mediators of inflammation in obesity and its comorbidities

1 reference

12 December 2020

T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity

1 reference

12 December 2020

Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia

1 reference

12 December 2020

Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice

1 reference

12 December 2020

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

1 reference

12 December 2020

Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice

1 reference

12 December 2020

Salicylate-induced hypoglycemia and ketoacidosis in a nondiabetic adult

1 reference

12 December 2020

Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding

1 reference

12 December 2020

Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice

1 reference

12 December 2020

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance

1 reference

12 December 2020